GlassScriptPhysician profile
Merry Bracken
NPI 1760987317
$6,321.59
in general payments reported to CMS, 2019-2025
15 companies · $182 in 2025
The $182 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,937 · 2024: $4,203 · 2025: $182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,507 · Travel and Lodging: $2,725 · Education: $90.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,507.04 |
| Travel and Lodging | $2,724.55 |
| Education | $90.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,457.71 | 2023-2025 | Synchromedii, Intellis Adaptivestim |
| Curonix LLC | $1,504.07 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Collegium Pharmaceutical, INC. | $417.36 | 2023-2025 | Belbuca, Xtampza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $269.46 | 2023-2024 | Relistor |
| Stryker Corporation | $150.00 | 2024 | Mild Device Kit |
| Forte Bio-Pharma LLC | $94.01 | 2023 | Prolate, Nalocet |
| Scilex Pharmaceuticals INC. | $88.71 | 2023-2024 | Ztlido |
| Foundation Fusion Solutions, LLC | $80.79 | 2024-2025 | |
| Abbvie INC. | $69.08 | 2023 | |
| Vertos Medical, INC. | $66.81 | 2024 | Mild Device Kit |
| Averitas Pharma INC. | $46.00 | 2023 | Qutenza |
| Boston Scientific Corporation | $22.47 | 2025 | General - Pain Management |
| Protega Pharmaceutials INC | $21.59 | 2024 | Roxybond |
| Nalu Medical, INC. | $17.82 | 2023 | Nalu Neurostimulation System |
| Pacira Pharmaceuticals Incorporated | $15.71 | 2025 | Iovera, Zilretta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Merry Bracken listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.